Search
Publication
Gonococcal antimicrobial susceptibility surveillance in Europe, 2018
The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC) since 2009. This surveillance is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform treatment guidelines.
Publication
Country visit to Ireland to discuss policies relating to antimicrobial resistance
ECDC and the European Commission's Directorate General for Health and Food Safety jointly carried out this country visit to Ireland from 7 to 11 October 2019. The visit was carried out following the invitation from the competent authorities to assist them in the development and implementation of their national strategy for tackling antimicrobial resistance (AMR) based on a 'One Health' approach.
Data
EARS-Net Reporting protocol 2020
Reporting protocol for submitting data on antimicrobial resistance to ECDC, through the European Antimicrobial Resistance Surveillance Network (EARS-Net).
Publication
The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2017/2018
Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and
food are collected annually by the EU Member States (MSs), jointly analysed by EFSA and ECDC and
reported in a yearly EU Summary Report.
Publication
Rapid risk assessment: Increase in OXA -244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013
Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
Publication
Rapid risk assessment: Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019
Between 1st February and 26th November 2019, 199 cases of Klebsiella pneumoniae carbapenemase (KPC)-producing carbapenem-resistant Enterobacterales (KPC-CRE) have been detected in Lithuania.
Publication
European surveillance of Clostridioides (Clostridium) difficile infections - surveillance protocol version 2.4
ECDC publishes a protocol developed for the surveillance of Clostridioides (Clostridium) difficile infections (CDI) to address the lack of standardised surveillance of CDI in EU Member States.
Peer-Reviewed Publication
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area
Cole, M.J., Quinten, C., Jacobsson, S., Day, M., Amato-Gauci, A.J., Woodford, N., Spiteri, G., Unemo, M., Stary, A., Haller, M., Verbrugge, R., Crucitti, T., Soteriou, S., Pieridou, D., Cowan, S., Hoffmann, S., Epstein, J., Viktorova, J., Ndeikoundam, N., Goubard, A., Kohl, P., Buder, S., Bremer, V., Tzelepi, E., Konte, V., Balla, E., Dudás, M., Sigmundsdóttir, G., Hauksdóttir, G.S., Igoe, D., Crowley, B., Suligoi, B., Stefanelli, P., Pakarna, G., Mavcutko, V., Barbara, C., Melillo, J.M., Van Dam, A., Van Benthem, B., Linde, I., Kløvstad, H., Bergheim, T., Majewski, S., Mlynarczyk-Bonikowska, B., Azevedo, J., Borrego, M.J., Pavlik, P., Truska, P., Klavs, I., Jeverica, S., Vazquez, J., Diez, M., Velicko, I., Unemo, M., Hughes, G., Eastick, K.
Publication
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018
This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.